Back to search

National and Kapodistrian University of Athens

Μελέτη των νευρολογικών εκδηλώσεων σε ασθενείς με πλασματοκυτταρικές δυσκρασίες ως αποτέλεσμα εκδήλωσης της βασικής νόσου ή νευροτοξικής θεραπείας

Abstract

dc:description

Paraprotein related peripheral neuropathy (PN) is frequently associated with treatment administration. Vincristine, thalidomide and more recently bortezomib are common neurotoxic agents inducing PN. The purpose of the present study was to evaluate Bortezomib Induced Peripheral Neuropathy (BIPN) by Total Neuropathy Score reduced version (TNSr), in an attempt to report as objectively as possible on the type, grade, duration and reversibility of neuropathy..We also attempted to investigate possible PN risk factors such as age, previous neurotoxic therapies, laboratory parameters, as well as to detect the best way to manage it.We studied 62 ΜΜ patients (52 with MM and 10 with macroglobulinemia Waldenstrom). There were 27 men and 25 women. Neuropathy was graded using Total Neuropathy Score (TNS) which ranged from 0 to 32 points (TNS reduced version). TNS evaluation included sensory and motor symptoms, pin and vibration sensibility, strength evaluation, tendon reflexes’ examination, sural and peroneal amplitude evaluation. Evidence of neuropathy was considered when the score was equal or greater than two. Patients with TNSr 2-8 presented with neuropathy of grade 1, TNSr 9-16 of grade 2, TNSr 17–24 of grade 3 and TNSr 24-32 of grade 4. Neurophysiological studies comprised two peripheral nerve calculations: the compound muscle action potential amplitude of peroneal nerve (CMAP) and the sensory nerve action potential amplitude of sural nerve (SNAP). The majority of patients developed grade 2 PN (TNS 9-16), as well as admixed sensory and motor symptoms. Median time to PN onset of any grade was 60 days (range 4 – 126 days), the majority of patients developed PN within the first 3 cycles after bortezomib initiation regardless of previous neurotoxic treatment. The predominant sensory PN symptoms were numbness and neuropathic pain whereas burnings, tinglings and paresthesias were less common. Pain was described as intensive, with sharp characteristics, like cold or electric evacuations, more annoying during night. Distal axonopathy was the most common form of BIPN. Nerve conduction study evaluation showed a predominantly sensory axonal polyneuropathy, followed by sensory motor of axonal type and pure motor axonal BIPN. In the majority of patients there was a concordance between patients’ symptoms and neurophysiological findings. However, in 20% of patients there was an underestimation of BIPN which was detected by neurophysiological evaluation despite the absence of clinical symptoms and/or signs of PN. Moreover, neurological examination included both clinical and laboratory criteria, revealed that there was an overestimation of PN by the physician in 16% of patients.In conclusion, bortezomib administration affects peripheral nerves and dorsal root ganglia (DRG) neurons, through proteasome inhibition. Statistical analysis of our data did not confirm any association among PN and age or previous neurotoxic therapies such as thalidomide and vincristine, as predisposing factors.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zarouli, Chrysothea
  • Ζαρούλη, Χρυσοθέα

Subjects

dc:subject × 9

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40455

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zarouli, Chrysothea; Ζαρούλη, Χρυσοθέα. Μελέτη των νευρολογικών εκδηλώσεων σε ασθενείς με πλασματοκυτταρικές δυσκρασίες ως αποτέλεσμα εκδήλωσης της βασικής νόσου ή νευροτοξικής θεραπείας. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/40455